Ask AI
ProCE Banner Activity

ExpressPoints Immuno-Oncology Combinations in Advanced RCC: Building on Recent Progress

Slideset

Download this short summary slideset of key takeaways from a live CCO series focused on key data for management of patients with RCC.

Released: July 07, 2020

Review Activity

Share

Provided by

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by a medical education grant from Exelixis, Inc.

Supported by an independent educational grant from Merck & Co., Inc.

Supported by educational grants from

Eisai

Pfizer, Inc.

Faculty Disclosure

Primary Author

Robert Motzer, MD

Jack and Dorothy Byrne Chair in Clinical Oncology
Kidney Cancer Section Head, Attending Physician
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Robert Motzer, MD: consultant: Merck; researcher (paid to institution): Bristol Myers Squibb, Eisai, Exelixis, Merck.